Simson Pharma reference standards
Reference standards published in the Simson Pharma catalogue, listed with CAS number, molecular formula, molecular weight and structure where available.
17,015 products · 284 pages
Simson Pharma products
-
Methyl 4-acetoxybenzoate
CUSTOM SYNTHESISRS-U211MIY -
Larotrectinib D4 sulfate
BACK ORDERRS-U205MPV -
Lemon Grass Oil
IN STOCKRS-U205MPW -
Lake Erythrosine R1-3703
BACK ORDERRS-U205MPX -
Lake Brill Blue R1-3703
CUSTOM SYNTHESISRS-U205MPY -
Lake Carmosine R1-3704
CUSTOM SYNTHESISRS-U205MPZ -
Lanthanum Carbonate Tetrahydrate Form I
BACK ORDERRS-U205MQ0 -
Lanthanum Carbonate Tetrahydrate Form II
BACK ORDERRS-U205MQ1 -
Lanreotide Parallel dimer X1
BACK ORDERRS-U205MQ2 -
Lanreotide Anti-parallel dimer X2
CUSTOM SYNTHESISRS-U205MQ3 -
Lanreotide Anti-parallel Dimer
BACK ORDERRS-U205MQ4 -
Lanreotide Parallel Dimer
BACK ORDERRS-U205MQ5 -
Larotrectinib Open-Ring Dimer
BACK ORDERRS-U205MQ6 -
trans-2-Hepten-1-ol
IN STOCKRS-U211MSU -
Rosehip Extract
CUSTOM SYNTHESISRS-U206MTY -
Rhodium 5% on aluminium
IN STOCKRS-U206MTZ -
Riboside
BACK ORDERRS-U206MU0 -
Residual Solvents Class 2-Mixture B
BACK ORDERRS-U206MU1 -
REP-6 R Isomer
CUSTOM SYNTHESISRS-U206MU2 -
Risperidone Benzoyl Impurity Hydrochloride
IN STOCKRS-U206MU3 -
Risperidone Impurity A and B Mixture
BACK ORDERRS-U206MU4 -
Risperidone Related Compounds Mixture
BACK ORDERRS-U206MU5 -
Ropivacaine N-Oxide(R isomer)
IN STOCKRS-U206MU6 -
Riboflavin 5`-monophosphate Mono Sodium Dihydrate
BACK ORDERRS-U206MU7 -
Riboflavin 5`-(Dihydrogen Phosphate) Monosodium Salt Dihydrate
BACK ORDERRS-U206MU8 -
Risperidone Quaternary Salt Impurity with chloride
BACK ORDERRS-U206MU9 -
Riboflavin-D7
BACK ORDERRS-U206MUA -
Rivastigmine Ortho Isomer
IN STOCKRS-U206MUB -
Rivastigmine Para Isomer
IN STOCKRS-U206MUC -
Riboflavin 4`,5`-Diphosphate (hexasodium salt)
BACK ORDERRS-U206MUE -
Riboflavin 3`,5`-Diphosphate (hexasodium salt)
BACK ORDERRS-U206MUF -
rhPTH (1-30) Trifluoroacetate
CUSTOM SYNTHESISRS-U206MUG -
6-[3-(1-adamantyl)-4-methoxyphenyl]2-formyl cinnamaldehyde one
BACK ORDERRS-U202MUH -
Robenidine D8 Hydrochloride
IN STOCKRS-U206MUH -
6-(9H-purin-2-ylthio)-9H-purine
IN STOCKRS-U202MUI -
Resmeticarbamic Acid
CUSTOM SYNTHESISRS-U206MUI -
6-(2-Imidazoline-2-ylamino)quinoxaline
IN STOCKRS-U202MUJ -
Riboflavin D8
IN STOCKRS-U206MUJ -
6,7-dihydrothieno (3,2-c) pyridine
IN STOCKRS-U202MUK -
D-Camphene
CUSTOM SYNTHESISRS-U204MUK -
5-Methoxy-6-(methoxycarbonyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-3-carboxylic acid
CUSTOM SYNTHESISRS-U202MUL -
Cyclosporin D4
CUSTOM SYNTHESISRS-U204MUL -
6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione
IN STOCKRS-U202MUM -
Cytidine-2,3-cyclic Monophosphate Sodium Salt
IN STOCKRS-U204MUM -
5-methoxy-3-methyl-1-phenyl-1H-Pyrazole
IN STOCKRS-U202MUN -
D-Asn-Desmopressin
BACK ORDERRS-U204MUN -
6,7-Bis(2-Methoxyethoxy)-N-(3-ethylphenyl)-N-(2-methoxyethyl)quinazolin-4-amine
CUSTOM SYNTHESISRS-U202MUO -
Icatibant Peptide Fragment [D-Cis-Hyp4]
BACK ORDERRS-U204MUO -
5-methoxy-1-nitroso-1H-benzo[d]imidazole-2-thiol
IN STOCKRS-U202MUP -
D-Arg-Arg-Pro-Hyp-Gly-Thi-D-Ser-D-Tic-Oic-Arg-OH
BACK ORDERRS-U204MUP -
5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1-nitroso-1H-benzo[d]imidazole
CUSTOM SYNTHESISRS-U202MUQ -
[D-ala2]-Liraglutide
BACK ORDERRS-U204MUQ -
5-[(R)-2-tetrahydrofuranyl]-thiazole-4-carboxylic acid
IN STOCKRS-U202MUR -
D-Asn AVP
BACK ORDERRS-U204MUR -
Cytidine 5`-Triphosphate Disodium
BACK ORDERRS-U204MUS -
D-(-)-Norgestrel Sulfate Sodium Salt
BACK ORDERRS-U204MUT -
D-Arg Isomeric Trifluoroacetate
BACK ORDERRS-U204MUU -
6-(3-bromo-2-chlorophenyl)-1,2,4-trazine-3,5-diamine
IN STOCKRS-U202MUV
17,015 products · 284 pages









![Chemical structure of 5-methoxy-1-nitroso-1H-benzo[d]imidazole-2-thiol](/structures/w4/WUDVXSBBQHHDDL-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1-nitroso-1H-benzo[d]imidazole](/structures/w4/RXRCWRSHQGHKIS-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of 5-[(R)-2-tetrahydrofuranyl]-thiazole-4-carboxylic acid](/structures/w4/XZUWAHCIQCKWFP-RXMQYKEDSA-N.webp?v=9)

